These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 19088272)
1. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. Witteveldt J; Evans MJ; Bitzegeio J; Koutsoudakis G; Owsianka AM; Angus AG; Keck ZY; Foung SK; Pietschmann T; Rice CM; Patel AH J Gen Virol; 2009 Jan; 90(Pt 1):48-58. PubMed ID: 19088272 [TBL] [Abstract][Full Text] [Related]
2. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Rothwangl KB; Manicassamy B; Uprichard SL; Rong L Virol J; 2008 Mar; 5():46. PubMed ID: 18355410 [TBL] [Abstract][Full Text] [Related]
4. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. Keck ZY; Li SH; Xia J; von Hahn T; Balfe P; McKeating JA; Witteveldt J; Patel AH; Alter H; Rice CM; Foung SK J Virol; 2009 Jun; 83(12):6149-60. PubMed ID: 19321602 [TBL] [Abstract][Full Text] [Related]
5. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection. Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607 [TBL] [Abstract][Full Text] [Related]
6. Diverse CD81 proteins support hepatitis C virus infection. Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Hsu M; Zhang J; Flint M; Logvinoff C; Cheng-Mayer C; Rice CM; McKeating JA Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7271-6. PubMed ID: 12761383 [TBL] [Abstract][Full Text] [Related]
8. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Timpe JM; Stamataki Z; Jennings A; Hu K; Farquhar MJ; Harris HJ; Schwarz A; Desombere I; Roels GL; Balfe P; McKeating JA Hepatology; 2008 Jan; 47(1):17-24. PubMed ID: 17941058 [TBL] [Abstract][Full Text] [Related]
10. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. Owsianka AM; Timms JM; Tarr AW; Brown RJ; Hickling TP; Szwejk A; Bienkowska-Szewczyk K; Thomson BJ; Patel AH; Ball JK J Virol; 2006 Sep; 80(17):8695-704. PubMed ID: 16912317 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus entry: potential receptors and their biological functions. Cocquerel L; Voisset C; Dubuisson J J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507 [TBL] [Abstract][Full Text] [Related]
13. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648 [TBL] [Abstract][Full Text] [Related]
15. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300 [TBL] [Abstract][Full Text] [Related]
16. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry. Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement. Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201 [TBL] [Abstract][Full Text] [Related]
18. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection. Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233 [TBL] [Abstract][Full Text] [Related]
19. CD81 is an entry coreceptor for hepatitis C virus. Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813 [TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles. Russell RS; Kawaguchi K; Meunier JC; Takikawa S; Faulk K; Bukh J; Purcell RH; Emerson SU J Viral Hepat; 2009 Sep; 16(9):621-32. PubMed ID: 19302336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]